Article
Hippo pathway effector Yap is an ovarian cancer oncogene.
Cancer research - 1 Nov 2010
Hall Chad A, Wang Runsheng, Miao Jiangyong, Oliva Esther, Shen Xiaoyun, Wheeler Thomas, Hilsenbeck Susan G, Orsulic Sandra, Goode Scott
Abstract excerpt
The Hippo pathway regulates organ size and tumorigenesis in Drosophila and mammals and is altered in a variety of human cancers, yet it remains unclear if the Hippo pathway is of prognostic significance to cancer patients. Here we show that the key targets of Hippo signaling, transcriptional coactivators Yki and Yap, play a conserved role in promoting ovarian cancer in flies and humans, respectively. Whereas...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
